Literature DB >> 3409843

Fatal aplastic anemia in a patient treated with carbamazepine.

M Franceschi1, G Ciboddo, G Truci, A Borri, N Canal.   

Abstract

A case of fatal aplastic anemia due to carbamazepine treatment in an epileptic woman is reported. Despite concerns of fatal bone marrow toxicity due to carbamazepine, this is only the fourth documented and published report. Carbamazepine is a safe drug, but physicians and patients should be aware of the exceedingly rare but potentially fatal side effects, better prevented by clinical than by laboratory monitoring.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409843     DOI: 10.1111/j.1528-1157.1988.tb03765.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

Review 1.  Neuromodulators for pain management in rheumatoid arthritis.

Authors:  Bethan L Richards; Samuel L Whittle; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

2.  The Relationship of Drug Therapy to Aplastic Anemia in Pakistan: A Hospital-Based Case Control Study.

Authors:  Muhammad Asif Syed; Aneela Atta Ur Rahman; Muhammad Nadeem Shah Syed; Naveed Masood Memon
Journal:  Ther Clin Risk Manag       Date:  2021-08-27       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.